Compounds > norethindrone

norethindrone and Cancer of Endometrium

norethindrone has been researched along with Cancer of Endometrium in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's6 (46.15)18.2507
2000's5 (38.46)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karakus, C; Simsek, T; Trak, B1
Bicknell, R; MacKenzie, IZ; Oehler, MK; Rees, MC; Wallwiener, D1
Coppens, M; Thiery, M1
Kaunitz, AM1
Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ1
Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studard, E1
Arguinzoniz, M; Boschitsch, E; Concin, H; De Geyter, C; Ehrenborg, A; Heikkinen, J; Hobson, R; Ibarra de Palacios, P; Samsioe, G; Scheurer, C; Schmidt, G1
Barbuto, DA; Judd, HL; Karlan, BY; Lagasse, LD; Leuchter, RS; McGonigle, KF1
Cerin, A; Heldaas, K; Moeller, B1
Hyder, SM; Murthy, L; Stancel, GM1
Gruber, DM; Huber, JC; Kurz, C; Sator, MO; Wagner, G1
Niwa, K; Tamaya, T; Yokoyama, Y1

Trials

3 trial(s) available for norethindrone and Cancer of Endometrium

ArticleYear
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
    Maturitas, 2002, Jul-25, Volume: 42, Issue:3

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms

2002
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
    Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Risk Assessment; Risk Factors; Treatment Outcome

2006
Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group.
    The New England journal of medicine, 1996, Mar-07, Volume: 334, Issue:10

    Topics: Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone

1996

Other Studies

10 other study(ies) available for norethindrone and Cancer of Endometrium

ArticleYear
Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia.
    Cancer letters, 2002, Dec-01, Volume: 186, Issue:1

    Topics: Cells, Cultured; Endometrial Neoplasms; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression Regulation; Humans; Norethindrone; Norethindrone Acetate; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; RNA, Messenger; Up-Regulation; Wnt Proteins

2002
Statement on injectable contraception.
    IPPF medical bulletin, 1982, Volume: 16, Issue:6

    Topics: Animals, Laboratory; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Organizations; Research; Steroids; Uterine Cervical Neoplasms

1982
Endometrial response to the use of a sequential oral contraceptive.
    Journal of obstetrics and gynaecology, 1988, Volume: 8, Issue:3

    Topics: Anatomy; Belgium; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Endometrium; Europe; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Mestranol; Neoplasms; Norethindrone; Physiology; Reproductive Control Agents; Risk Factors; Urogenital System; Uterus

1988
Injectable contraception: the USA perspective.
    IPPF medical bulletin, 1992, Volume: 26, Issue:6

    Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service

1992
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
    Fertility and sterility, 2004, Volume: 81, Issue:1

    Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2004
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Polyps; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Retrospective Studies

2004
Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
    Gynecologic oncology, 1994, Volume: 55, Issue:1

    Topics: Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Progestins; Retrospective Studies

1994
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Cancer research, 1998, Feb-01, Volume: 58, Issue:3

    Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1998
Endometrial cancer after combined hormone replacement therapy.
    Maturitas, 1999, Mar-15, Volume: 31, Issue:3

    Topics: Adenocarcinoma; Endometrial Neoplasms; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Time Factors

1999
Norethindrone scatters silver-stained nucleolar organizer regions of Ishikawa cells.
    Cancer research, 1991, Nov-01, Volume: 51, Issue:21

    Topics: Cell Line; DNA Replication; Endometrial Neoplasms; Female; Gonadal Steroid Hormones; Hormones; Humans; Kinetics; Microscopy, Electron; Norethindrone; Nucleolus Organizer Region; RNA, Neoplasm; Silver; Staining and Labeling; Steroids

1991